[go: up one dir, main page]

WO2008145170A1 - Procédé pour configurer un système d'automatisation - Google Patents

Procédé pour configurer un système d'automatisation Download PDF

Info

Publication number
WO2008145170A1
WO2008145170A1 PCT/EP2007/005027 EP2007005027W WO2008145170A1 WO 2008145170 A1 WO2008145170 A1 WO 2008145170A1 EP 2007005027 W EP2007005027 W EP 2007005027W WO 2008145170 A1 WO2008145170 A1 WO 2008145170A1
Authority
WO
WIPO (PCT)
Prior art keywords
automation
information
setting information
devices
device setting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/005027
Other languages
German (de)
English (en)
Inventor
Jürgen BAUEREISS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens AG
Siemens Corp
Original Assignee
Siemens AG
Siemens Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens AG, Siemens Corp filed Critical Siemens AG
Priority to PCT/EP2007/005027 priority Critical patent/WO2008145170A1/fr
Publication of WO2008145170A1 publication Critical patent/WO2008145170A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B19/00—Programme-control systems
    • G05B19/02—Programme-control systems electric
    • G05B19/04—Programme control other than numerical control, i.e. in sequence controllers or logic controllers
    • G05B19/042—Programme control other than numerical control, i.e. in sequence controllers or logic controllers using digital processors
    • G05B19/0426—Programming the control sequence
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/20—Pc systems
    • G05B2219/25—Pc structure of the system
    • G05B2219/25106—Pluggable card, magnetic, smart with configuration data, pulled out after loading
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/31—From computer integrated manufacturing till monitoring
    • G05B2219/31102—Program network controller, connected devices
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/31—From computer integrated manufacturing till monitoring
    • G05B2219/31106—Auto configuration, each module responsable for own configuration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P90/00—Enabling technologies with a potential contribution to greenhouse gas [GHG] emissions mitigation
    • Y02P90/02—Total factory control, e.g. smart factories, flexible manufacturing systems [FMS] or integrated manufacturing systems [IMS]

Definitions

  • automation devices For controlling and monitoring electrical energy supply networks usually automation devices, such.
  • power quality devices devices for monitoring the quality of electrical energy
  • an automation system must be configured with regard to its concrete use by setting adjustable functions of the automation devices in the desired manner.
  • adjustable functions of the automation devices In such adjustable
  • Functions of the automation devices may be, for example, the setting of communication addresses, by means of which the respective automation devices can communicate via one or more communication buses.
  • it can be the setting of certain rules that determine how the automation devices should react to certain situations, such as an error occurring in the electrical energy supply network.
  • the automation devices must be given, for example, whether they should automatically initiate appropriate countermeasures and / or transmit a message about the error to another automation device or a central control center.
  • a so-called parameter set has hitherto usually been generated for each automation device by means of a personal computer.
  • This parameter set contains the settings of the respective automation device.
  • the parameter set thus generated is then transmitted to the corresponding automation device, for example via a temporarily established serial data connection, where it is used to set the adjustable functions of the electrical system.
  • Such a method is known, for example, from the system description of the protective device series "SIPROTEC 4" from Siemens AG dated 24.08.2006 with the order number E50417-H1100-C151-A8, in particular from section 1.4 "Parameterization".
  • the user To create a parameter set in the manner described, the user must have knowledge of a parameter structure of the individual automation devices, the mode of action of the individual adjustable functions and knowledge of parameters specific to the entire automation system. Such a method is relatively time consuming and comparatively prone to user input errors.
  • the invention has for its object to provide a method for configuring an automation system, which can be performed with relatively little effort and has a reduced error rate for incorrect entries of a user.
  • This object is achieved according to the invention by a method for configuring an automation system comprising at least two automation devices, wherein the automation devices have adjustable functions and the following steps are carried out in the method:
  • setup information Using the setup information to generate first device setup information
  • the particular advantage of the method according to the invention is that it manages with a minimum number of settings to be made by the user.
  • the user merely has to ensure that a design information describing the structure of the automation system is provided correctly.
  • this setup information which comprises, for example, a so-called “single-line display" of the section of the power supply network monitored and controlled by the automation system
  • the first automation device automatically automatically sets itself up, for example selecting a communication address
  • the settings made are transmitted in the form of a first device setting information together with the setup information to the second automation device, which in turn adjusts itself hereby.
  • An advantageous embodiment of the method according to the invention provides that for each additional (ie beyond the number of two automation devices) automation device, the steps e) to g) are repeated such that - In step e) the setup information and all device setting information of the already set automation devices are respectively transmitted to the automation device currently to be set;
  • step f) the functions of the automation device currently to be set are automatically set by a data processing device of the automation device currently to be set using the respectively transmitted setup information and the transmitted device setting information, generating a respective device setting information of the automation device currently to be set. the;
  • step g) the device setting information of the currently set automation device is added to the setup information and the device setting information of the already set automation devices.
  • an automation system can be configured with any number of automation devices, with each individual automation device, when setting its functions, each accessing the setup information and all device setting information of the previously set automation devices.
  • a further advantageous embodiment of the method according to the invention provides that after setting the last automation device of the automation system, the device setting information of all set automation devices to a data processing device central system control device of the automation system are transmitted and the data processing device of the central system control device automatically sets the functions of the central system control device using the device setting information.
  • a central system control device for example a higher-level station control device, with the device setting information of all automation devices of the automation system, so that the system control device can hereby automatically set its own functions for controlling the individual automation devices.
  • a further advantageous embodiment of the method according to the invention also provides that the setup information is provided on an external data memory, the transmission of the setup information and the respective device setting information by reading the external data memory by means of the data processing device of the respective automation device and the addition of the respective device setting information by writing the external data memory by means of the data processing device of the respective automation device takes place.
  • Figure 1 is a schematic representation of a monitored and / or controlled by means of an automation system section of an electrical energy supply network and
  • FIG. 2 shows a process flow diagram for explaining the
  • FIG. 1 shows a section 10 of an otherwise not further illustrated electrical energy supply network.
  • the section 10 comprises a busbar 11, which is fed by a supply line 12. From the busbar 11 also go from three branches 13a, 13b and 13c.
  • an automation system is provided which has electrical automation devices 14a, 14b, 14c, 14d, 14e, 14f and 14g, a central system control device 15 and a process bus 16 and a control bus 17.
  • the exemplary embodiment according to FIG. 1 is electrical protection devices for monitoring the supply line 12 or the branches 13a, 13b and 13c.
  • These automation devices 14a to 14d are via command outputs with power switches 18a,
  • the automation device 14e is a so-called "power quality device" with which the electrical energy quality on the supply line 12 is monitored. For example, the automation device 14e determines the frequency of the fundamental oscillation of the current flowing in the supply line 12 current.
  • the automation devices 14f and 14g are control devices that are connected via the process bus 16 to the automation devices 14a to 14e and to each other.
  • commands can be sent to the programmable controllers 14a to 14e connected to the process bus 16, on the one hand, and messages from the automation devices 14a to 14e, on the other hand, can be received by means of the control devices.
  • Commands in this context may include, for example, a manually requested switching action of one of the power switches 18a to 18d; Messages, for example, the current status of the respective programmable controller 14a to 14e (eg "ready", "error", "associated circuit breaker open / closed") specify.
  • the automation devices 14f and 14g designed as control devices are connected via the control bus 17 to a central system control device 15 in the form of a control station.
  • commands can be generated by the operator of the automation system to the programmable controllers 14a to 14g.
  • Messages originating from the automation devices can be displayed with the central system control device 15 in order to display the state of the section 10 of the electrical power supply network to the operating personnel.
  • adjustable functions of the individual programmable controllers 14a to 14g are set accordingly.
  • Such adjustable functions can be, for example, one or more communication addresses with which the individual automation devices 14a to 14g can be addressed via the process bus 16 or the control bus 17.
  • it can be e.g. to set thresholds (e.g.
  • FIG. 2 schematically shows a process flow diagram with which it is intended to explain how the adjustment of the adjustable functions of the individual automation devices is carried out in order to configure the automation system.
  • an external data carrier 21 which is, for example, a USB stick, a floppy disk, a
  • an external data memory can be external data memories with respect to the automation devices, it is also possible for a mobile data processing device to be used as the external data memory to use with its own data storage (for example, a so-called PocketPC, a mobile phone or a laptop).
  • a mobile data processing device for example, a so-called PocketPC, a mobile phone or a laptop.
  • connection between the external data memory 21 and the respective automation device can be both a wired and a wireless connection, for example via infrared or Bluetooth.
  • setup information A about the structure of the automation system.
  • setup information may comprise, for example, the information shown schematically in FIG. 1 and thus provide information, for example, about the type and number of the automation devices 14a to 14g, their installation location and the type of communication buses used.
  • the structure information A is read from the external data memory 21.
  • the first automation apparatus 22a automatically sets its adjustable functions itself.
  • the first automation device 22a hereby parameterizes itself, so to speak, using the setup information A. Since only the setup information is stored on the external data memory 21 at this time, the first automation device 22a recognizes that so far no further
  • Automation device of the automation system has been set.
  • the automation device 22a selects, for example, one or more communication addresses from a set of permitted communication addresses. If the first automation device 22a is an electrical protection device or a power quality device, it defines, for example, a threshold value at which it detects an impermissible operating state in the section 10 of the electrical energy supply network.
  • a protection device In the case of a protection device, it can also specify a delay time with which it reacts to a fault.
  • the automation device 14a would set a greater delay time than the automation devices 14b, 14c and 14d, so that it reacts correspondingly slower to an error in one of the branches 13a to 13c and thus the programmable controllers 14b, 14c or 14c 14d have the possibility of switching off their branches 13a, 13b or 13c beforehand. If the automation device 22a has set all adjustable functions automatically, then it transmits a first device setting information G1 to the external data memory 21. This first device setting information G1 contains data indicating the settings made in the first automation device 22a.
  • the external data memory 21 is then disconnected from the first automation device 22a and connected in a following step 2OB to a second automation device 22b.
  • the data processing device of the second automation device 22b reads from the external data memory 21, the setup information A and the first device setting information Gl and uses this information as a basis for setting their own adjustable functions. For example, the automation device 22b selects one or more of the remaining permitted communication addresses. Since the automation device 22a has already selected one or more communication addresses, the automation device 22b must select from the remaining permitted communication addresses.
  • the second automation device 22b also automatically makes all other settings and transmits a second device setting information G2, which indicates the settings made in the second automation device 22b, to the external data memory 21.
  • the external data memory 21 is then disconnected from the second automation device 22b and connected to a third automation device 22c in a next step 20C.
  • the data processing device of the third automation device 22c reads from the external data memory 21, the setup information A and the first and second device setting information Gl and G2 and provides with knowledge of this information its own adjustable Functionally. Thereafter, the third automation device 22 c transmits third device setting information to the external data memory 21.
  • each automation device to be set reads the setup information A and the device setting information, e.g. Gl, G2, G3, the already set automation devices from the external data memory 21 and sets based on their own functions. After that, the automation device currently to be set up additionally describes the external data memory 21 with its own device setting information.
  • the last automation device 22 n of the automation system is set. It reads from the external data memory 21 the setup information A and the device setting information, e.g. Gl, G2, G3, of the previously set automation devices, automatically sets its functions on the basis thereof and transmits an nth device setting information Gn to the external data storage device 21.
  • the automation system is thus completely set with respect to its automation system.
  • Step 24 the respective device setting information to a central system control device 25, which corresponds for example to the central system control device 15 in Figure 1, to be transmitted.
  • a central system control device 25 which corresponds for example to the central system control device 15 in Figure 1
  • the construction information A should already be present on the central system control device 25; should this not be the case, then the construction information A is to be transmitted to the central system control device 25.
  • the central system controller 25 automatically determines the setting of its own adjustable functions. For example, in this case each automation device 22a to 22n of the automation system is assigned the communication address which it has itself selected in its previous setting. In this way, the central system control device 25 can also be set comparatively easily and without the risk of possible manual incorrect inputs by a user with regard to the automation devices 22a to 22n.
  • the (possibly updated) setup information A and the device setting information of the existing automation devices are correspondingly transmitted to the newly added automation device. This then automatically sets its own functions and generates a new device setting information. With this new device setting Finally, the central system control device can set its functions in such a way that in the future the newly added automation device is taken into account.
  • the setup information A and the individual device setting information are transmitted by means of an external data memory 21 to the respective automation devices 22a to 22n or the central system control device 25, an already existing one instead of the external data memory 21 Communication bus, for example, the control bus 17 and / or the process bus 16 according to Figure 1, are used.
  • the external data memory 21 can be dispensed with.

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Automation & Control Theory (AREA)
  • Remote Monitoring And Control Of Power-Distribution Networks (AREA)

Abstract

L'objectif de l'invention est de réduire les dépenses et la sensibilité aux erreurs pour des entrées erronées, lors de la configuration d'un système d'automatisation. A cet effet, un procédé de configuration d'un système d'automatisation est utilisé, selon lequel les appareils d'automatisation (22a à 22n) présentent des fonctions réglables. Le procédé de l'invention comprend les étapes suivantes: a) mise à disposition d'informations structurelles concernant la structure du système d'automatisation (A); b) transmission des informations structurelles à un premier appareil d'automatisation (22a); c) réglage automatique des fonctions du premier appareil d'automatisation au moyen d'un dispositif de traitement de données du premier appareil d'automatisation, lors de l'utilisation des informations structurelles, lors de la production de premières informations (GI) concernant le réglage des appareils; d) ajout des premières informations concernant le réglage des appareils aux informations structurelles; e) transmission des informations structurelles et des premières informations concernant le réglage des appareils à un second appareil d'automatisation (22b); f) réglage automatique des fonctions du second appareil d'automatisation à l'aide d'un dispositif de traitement des données du second appareil d'automatisation, lors de l'utilisation des informations structurelles et des premières informations concernant le réglage des appareils, lors de la production de secondes informations concernant le réglage des appareils; g) ajout des secondes informations (G2) concernant le réglage des appareils auxdonnées structurelles et aux premières informations concernant le réglage des appareils.
PCT/EP2007/005027 2007-05-31 2007-05-31 Procédé pour configurer un système d'automatisation Ceased WO2008145170A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/005027 WO2008145170A1 (fr) 2007-05-31 2007-05-31 Procédé pour configurer un système d'automatisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/005027 WO2008145170A1 (fr) 2007-05-31 2007-05-31 Procédé pour configurer un système d'automatisation

Publications (1)

Publication Number Publication Date
WO2008145170A1 true WO2008145170A1 (fr) 2008-12-04

Family

ID=39271131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/005027 Ceased WO2008145170A1 (fr) 2007-05-31 2007-05-31 Procédé pour configurer un système d'automatisation

Country Status (1)

Country Link
WO (1) WO2008145170A1 (fr)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITVR20100084A1 (it) * 2010-04-26 2011-10-27 Marco Bologna Apparato di controllo e comando per l attivazione di macchinari in genere e trasporto di dati.
US9056088B2 (en) 2009-04-29 2015-06-16 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising fatty acids
US9060982B2 (en) 2009-04-29 2015-06-23 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US9603826B2 (en) 2012-06-29 2017-03-28 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
US10166209B2 (en) 2013-02-06 2019-01-01 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10314803B2 (en) 2008-09-02 2019-06-11 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10493058B2 (en) 2009-09-23 2019-12-03 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US10537544B2 (en) 2011-11-07 2020-01-21 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10668042B2 (en) 2018-09-24 2020-06-02 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US10842768B2 (en) 2009-06-15 2020-11-24 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides
US10888539B2 (en) 2013-09-04 2021-01-12 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
US11141399B2 (en) 2012-12-31 2021-10-12 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US11179362B2 (en) 2012-11-06 2021-11-23 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2022184556A1 (fr) * 2021-03-04 2022-09-09 Leica Microsystems Cms Gmbh Dispositif et procédé de fourniture de fonctionnalités
US11547710B2 (en) 2013-03-15 2023-01-10 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US11712428B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11986452B2 (en) 2021-04-21 2024-05-21 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
US12427134B2 (en) 2019-11-12 2025-09-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1211582A1 (fr) * 2000-11-30 2002-06-05 Siemens Building Technologies AG Dispositif de surveillance, de commande et de régulation d'une installation technique de système d'automation de bâtiments
EP1233316A2 (fr) * 2001-02-16 2002-08-21 Siemens Aktiengesellschaft Dispositif et méthode de manipulation des composants d'un système de commande automatique
WO2003019359A2 (fr) * 2001-08-20 2003-03-06 Siemens Aktiengesellschaft Procede et dispositif de configuration de groupes de composants dans un systeme de traitement de donnees
WO2005022279A1 (fr) * 2003-08-22 2005-03-10 Siemens Aktiengesellschaft Procede de parametrage de dispositifs d'automatisation, et dispositif d'automatisation correspondant
EP1643679A1 (fr) * 2004-09-29 2006-04-05 Siemens Aktiengesellschaft Configuration de modules dans des systèmes d'automatisation
WO2006128395A1 (fr) * 2005-06-01 2006-12-07 Siemens Aktiegesellschaft Appareil de parametrage et procede de parametrage d'appareils electriques

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1211582A1 (fr) * 2000-11-30 2002-06-05 Siemens Building Technologies AG Dispositif de surveillance, de commande et de régulation d'une installation technique de système d'automation de bâtiments
EP1233316A2 (fr) * 2001-02-16 2002-08-21 Siemens Aktiengesellschaft Dispositif et méthode de manipulation des composants d'un système de commande automatique
WO2003019359A2 (fr) * 2001-08-20 2003-03-06 Siemens Aktiengesellschaft Procede et dispositif de configuration de groupes de composants dans un systeme de traitement de donnees
WO2005022279A1 (fr) * 2003-08-22 2005-03-10 Siemens Aktiengesellschaft Procede de parametrage de dispositifs d'automatisation, et dispositif d'automatisation correspondant
EP1643679A1 (fr) * 2004-09-29 2006-04-05 Siemens Aktiengesellschaft Configuration de modules dans des systèmes d'automatisation
WO2006128395A1 (fr) * 2005-06-01 2006-12-07 Siemens Aktiegesellschaft Appareil de parametrage et procede de parametrage d'appareils electriques

Cited By (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10314803B2 (en) 2008-09-02 2019-06-11 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
US10265287B2 (en) 2009-04-29 2019-04-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing triglycerides and LDL-C
US10220013B2 (en) 2009-04-29 2019-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US9060983B2 (en) 2009-04-29 2015-06-23 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US9072715B2 (en) 2009-04-29 2015-07-07 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US9138415B2 (en) 2009-04-29 2015-09-22 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US9056088B2 (en) 2009-04-29 2015-06-16 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising fatty acids
US9585856B2 (en) 2009-04-29 2017-03-07 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US11213504B2 (en) 2009-04-29 2022-01-04 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US10624870B2 (en) 2009-04-29 2020-04-21 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US11154526B2 (en) 2009-04-29 2021-10-26 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US10792267B2 (en) 2009-04-29 2020-10-06 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US11033523B2 (en) 2009-04-29 2021-06-15 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
US11690820B2 (en) 2009-04-29 2023-07-04 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US10940131B2 (en) 2009-04-29 2021-03-09 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US10888537B2 (en) 2009-04-29 2021-01-12 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising omega-3 fatty acids
US10987331B2 (en) 2009-04-29 2021-04-27 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US9855237B2 (en) 2009-04-29 2018-01-02 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US10449172B2 (en) 2009-04-29 2019-10-22 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US9060982B2 (en) 2009-04-29 2015-06-23 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US11103477B2 (en) 2009-04-29 2021-08-31 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US11147787B2 (en) 2009-04-29 2021-10-19 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US11400069B2 (en) 2009-04-29 2022-08-02 Amarin Pharmaceuticals Ireland Limited Methods of treating mixed dyslipidemia
US10010517B2 (en) 2009-04-29 2018-07-03 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US10881632B2 (en) 2009-04-29 2021-01-05 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US10842766B2 (en) 2009-04-29 2020-11-24 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same
US12171738B2 (en) 2009-06-15 2024-12-24 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides
US11439618B2 (en) 2009-06-15 2022-09-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides
US10842768B2 (en) 2009-06-15 2020-11-24 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides
US11464757B2 (en) 2009-06-15 2022-10-11 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides
US11007173B2 (en) 2009-09-23 2021-05-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US10493058B2 (en) 2009-09-23 2019-12-03 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
ITVR20100084A1 (it) * 2010-04-26 2011-10-27 Marco Bologna Apparato di controllo e comando per l attivazione di macchinari in genere e trasporto di dati.
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712428B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US10632094B2 (en) 2011-11-07 2020-04-28 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US10537544B2 (en) 2011-11-07 2020-01-21 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US10973796B2 (en) 2012-01-06 2021-04-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject
US9827219B2 (en) 2012-01-06 2017-11-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject
US9693985B2 (en) 2012-06-29 2017-07-04 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10278938B2 (en) 2012-06-29 2019-05-07 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10383840B2 (en) 2012-06-29 2019-08-20 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
US10278939B2 (en) 2012-06-29 2019-05-07 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10555925B1 (en) 2012-06-29 2020-02-11 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
US10555924B2 (en) 2012-06-29 2020-02-11 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
US10278937B2 (en) 2012-06-29 2019-05-07 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10568861B1 (en) 2012-06-29 2020-02-25 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
US10576054B1 (en) 2012-06-29 2020-03-03 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
US9603826B2 (en) 2012-06-29 2017-03-28 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10278935B2 (en) 2012-06-29 2019-05-07 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10278936B2 (en) 2012-06-29 2019-05-07 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US9610272B2 (en) 2012-06-29 2017-04-04 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US9623001B2 (en) 2012-06-29 2017-04-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US9693984B2 (en) 2012-06-29 2017-07-04 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10894028B2 (en) 2012-06-29 2021-01-19 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
US9693986B2 (en) 2012-06-29 2017-07-04 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10792270B2 (en) 2012-06-29 2020-10-06 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
US9918955B2 (en) 2012-06-29 2018-03-20 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US10016386B2 (en) 2012-06-29 2018-07-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US9918954B2 (en) 2012-06-29 2018-03-20 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US11229618B2 (en) 2012-11-06 2022-01-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US11179362B2 (en) 2012-11-06 2021-11-23 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US11141399B2 (en) 2012-12-31 2021-10-12 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US10166209B2 (en) 2013-02-06 2019-01-01 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US10265290B2 (en) 2013-02-06 2019-04-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US10675263B2 (en) 2013-02-06 2020-06-09 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US11185525B2 (en) 2013-02-06 2021-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US10973797B2 (en) 2013-02-06 2021-04-13 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein c-III
US10610508B2 (en) 2013-02-06 2020-04-07 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US10167467B2 (en) 2013-02-13 2019-01-01 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10851374B2 (en) 2013-02-13 2020-12-01 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9855240B2 (en) 2013-02-19 2018-01-02 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US10206898B2 (en) 2013-03-14 2019-02-19 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US11547710B2 (en) 2013-03-15 2023-01-10 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US10888539B2 (en) 2013-09-04 2021-01-12 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US11285127B2 (en) 2013-10-10 2022-03-29 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10722485B2 (en) 2013-10-10 2020-07-28 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10292959B2 (en) 2013-10-10 2019-05-21 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US11052063B2 (en) 2014-06-11 2021-07-06 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US11446269B2 (en) 2014-06-16 2022-09-20 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10842765B2 (en) 2016-03-15 2020-11-24 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10966951B2 (en) 2017-05-19 2021-04-06 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
US10668042B2 (en) 2018-09-24 2020-06-02 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US11369582B2 (en) 2018-09-24 2022-06-28 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US10786478B2 (en) 2018-09-24 2020-09-29 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US11000499B2 (en) 2018-09-24 2021-05-11 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US11298333B1 (en) 2018-09-24 2022-04-12 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US11116742B2 (en) 2018-09-24 2021-09-14 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US11717504B2 (en) 2018-09-24 2023-08-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US11116743B2 (en) 2018-09-24 2021-09-14 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US12246003B2 (en) 2018-09-24 2025-03-11 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject
US12427134B2 (en) 2019-11-12 2025-09-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter
WO2022184556A1 (fr) * 2021-03-04 2022-09-09 Leica Microsystems Cms Gmbh Dispositif et procédé de fourniture de fonctionnalités
US11986452B2 (en) 2021-04-21 2024-05-21 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Similar Documents

Publication Publication Date Title
WO2008145170A1 (fr) Procédé pour configurer un système d'automatisation
EP1064759B1 (fr) Procede de mise en service d'un systeme bus et systeme bus en question
DE69818089T2 (de) Intelligentes kraftfahrzeugstromverteilungssystem und sein herstellungsverfahren
EP1430618B1 (fr) Procede pour faire fonctionner un systeme de transmission, et systeme de transmission dans un reseau d'alimentation electrique
EP2598954B1 (fr) Configuration des liaisons de communication des appareils de terrain d'un équipement d'automatisation de la distribution d'énergie
WO2005117245A1 (fr) Convertisseur solaire et dispositif photovoltaique comportant plusieurs convertisseurs solaires
EP2217973B1 (fr) Dispositif et procédé d'utilisation d'une éolienne ou d'un parc d'éoliennes
EP1427086B2 (fr) Appareil électrique et methode pour le faire fonctionner
DE102013209676A1 (de) Konfigurationssoftware und Verfahren zum Erstellen von Konfigurationsdaten und eines PLC-Programms für ein eine speicherprogrammierbare Steuerung umfassendes Steuer- und/oder Schutzgerät für die Mittel- oder Hochspannungstechnik
EP2684335B1 (fr) Installation d'automatisation d'énergie et procédé servant à faire fonctionner une installation d'automatisation d'énergie
DE102018102067A1 (de) Drahtloses IO-Link-Kommunikationsnetzwerk mit einem zusätzlichen Master und Verfahren zu dessen Betrieb
EP4170443A1 (fr) Dispositif de commande et procédé de commutation d'unités d'entrée/sortie d'un dispositif de commande
EP1999526A1 (fr) Gestion d'un bus de terrain sans fil
WO2009135512A1 (fr) Contrôle de la liaison de communication entre des appareils de terrain
EP2883294B1 (fr) Procédé de commande assistée par ordinateur d'un réseau de distribution d'énergie électrique composé d'une pluralité de noeuds
EP1690390A1 (fr) Procede de transmission de donnees via un bus de donnees, et systeme et passerelle permettant la mise en oeuvre dudit procede
EP2756575B1 (fr) Réseau de distribution d'énergie
DE3211020C1 (de) Übertragungs-Einrichtung zur Datenübermittlung zwischen einer Steuerzentrale und mehreren Regel- oder Steuergeräten eines Gebäudes
DE102022208624A1 (de) Vorrichtung und verfahren zur diagnose und konfiguration einer hydraulikvorrichtung basierend auf einem drahtlosen lokalen netzwerk
EP2594858A1 (fr) Procédé et système de télécommande de climatisations individuelles décentralisées sans interface de mise en réseau
DE10132036C2 (de) Automatisierungssystem und Verfahren mit Funktionen in einer Auszeichnungssprache
WO2012175135A1 (fr) Fonctionnement redondant d'une installation d'automatisation
WO2016079091A1 (fr) Procédé de fonctionnement d'un premier et d'au moins un deuxième appareil de terrain
DE60200059T2 (de) Vervaltung eines Kabellosse Beleuchtungsnetzwerk
EP3599689A1 (fr) Procédé de fonctionnement d'un réseau électrique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07725876

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07725876

Country of ref document: EP

Kind code of ref document: A1